Could Pyelonephritic Scarring Be Prevented by Anti-Inflammatory Treatment? An Experimental Model of Acute Pyelonephritis
Figure 2
(a) Control group kidney tissue which does not indicate any pathological finding in renal parenchyma (H.E 100). (b) 2nd degree inflammation in renal parenchyma, no-treatment group (HE 40). (c) 2nd degree scar in renal parenchyma, no-treatment group (M.T 40). (d) Ceftriaxone-ketoprofen group kidney tissue which does not indicate any pathological findings in renal parenchyma.
